Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]

Robert B Nussenblatt; Darby J.S Thompson; Zhuqing Li; Chi C Chan; Jan S Peterson; Randy R Robinson; Richard S Shames; Sudha Nagarajan; Meina Tao Tang; Michelle Mailman; Gisela Velez; Chandra Roy; Grace A Levy-Clarke; Eric B Sujler; Ali Djalilian; Hatice Nida Sen; Shadi Al-Khatib; Roxana Ursea; Sunil Srivastava; Allison Bamji; Susan Mellow; Pushpa Sran; Thomas A Waldmann; Ronald R Buggage

doi:10.1016/J.JAUT.2004.04.001

Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]

Robert B Nussenblatt
, Darby J.S Thompson
, Zhuqing Li
, Chi C Chan
, Jan S Peterson
, Randy R Robinson
, Richard S Shames
, Sudha Nagarajan
, Meina Tao Tang
, Michelle Mailman
, Gisela Velez
, Chandra Roy
, Grace A Levy-Clarke
, Eric B Sujler
, Ali Djalilian
, Hatice Nida Sen
, Shadi Al-Khatib
, Roxana Ursea
, Sunil Srivastava
, Allison Bamji

Susan Mellow, Pushpa Sran, Thomas A Waldmann, Ronald R Buggage

National Institutes of Health
The EMMES Corporation, Rockville, MD, USA
Protein Design Labs, Inc., Fremont, CA, USA

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Autoimmunity
Volume	23
Issue number	1
DOIs	https://doi.org/10.1016/J.JAUT.2004.04.001
State	Published - Aug 1 2004
Externally published	Yes

Disciplines

Immunology and Infectious Disease
Pharmacology
Medicine and Health Sciences

Access to Document

10.1016/J.JAUT.2004.04.001License: Unspecified

Cite this

Nussenblatt, R. B., Thompson, D. J. S., Li, Z., Chan, C. C., Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. T., Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Sujler, E. B., Djalilian, A., Sen, H. N., Al-Khatib, S., Ursea, R., Srivastava, S., ... Buggage, R. R. (2004). Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]. Journal of Autoimmunity, 23(1). https://doi.org/10.1016/J.JAUT.2004.04.001

Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]. / Nussenblatt, Robert B; Thompson, Darby J.S; Li, Zhuqing et al.
In: Journal of Autoimmunity, Vol. 23, No. 1, 01.08.2004.

Research output: Contribution to journal › Article › peer-review

Nussenblatt, RB, Thompson, DJS, Li, Z, Chan, CC, Peterson, JS, Robinson, RR, Shames, RS, Nagarajan, S, Tang, MT, Mailman, M, Velez, G, Roy, C, Levy-Clarke, GA, Sujler, EB, Djalilian, A, Sen, HN, Al-Khatib, S, Ursea, R, Srivastava, S, Bamji, A, Mellow, S, Sran, P, Waldmann, TA & Buggage, RR 2004, 'Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]', Journal of Autoimmunity, vol. 23, no. 1. https://doi.org/10.1016/J.JAUT.2004.04.001

Nussenblatt RB, Thompson DJS, Li Z, Chan CC, Peterson JS, Robinson RR et al. Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]. Journal of Autoimmunity. 2004 Aug 1;23(1). doi: 10.1016/J.JAUT.2004.04.001

Nussenblatt, Robert B ; Thompson, Darby J.S ; Li, Zhuqing et al. / Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]. In: Journal of Autoimmunity. 2004 ; Vol. 23, No. 1.

@article{d48c130721a3442c86ae684f6e614d09,

title = "Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]",

author = "Nussenblatt, \{Robert B\} and Thompson, \{Darby J.S\} and Zhuqing Li and Chan, \{Chi C\} and Peterson, \{Jan S\} and Robinson, \{Randy R\} and Shames, \{Richard S\} and Sudha Nagarajan and Tang, \{Meina Tao\} and Michelle Mailman and Gisela Velez and Chandra Roy and Levy-Clarke, \{Grace A\} and Sujler, \{Eric B\} and Ali Djalilian and Sen, \{Hatice Nida\} and Shadi Al-Khatib and Roxana Ursea and Sunil Srivastava and Allison Bamji and Susan Mellow and Pushpa Sran and Waldmann, \{Thomas A\} and Buggage, \{Ronald R\}",

year = "2004",

month = aug,

day = "1",

doi = "10.1016/J.JAUT.2004.04.001",

language = "American English",

volume = "23",

journal = "Journal of Autoimmunity",

number = "1",

}

TY - JOUR

T1 - Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]

AU - Nussenblatt, Robert B

AU - Thompson, Darby J.S

AU - Li, Zhuqing

AU - Chan, Chi C

AU - Peterson, Jan S

AU - Robinson, Randy R

AU - Shames, Richard S

AU - Nagarajan, Sudha

AU - Tang, Meina Tao

AU - Mailman, Michelle

AU - Velez, Gisela

AU - Roy, Chandra

AU - Levy-Clarke, Grace A

AU - Sujler, Eric B

AU - Djalilian, Ali

AU - Sen, Hatice Nida

AU - Al-Khatib, Shadi

AU - Ursea, Roxana

AU - Srivastava, Sunil

AU - Bamji, Allison

AU - Mellow, Susan

AU - Sran, Pushpa

AU - Waldmann, Thomas A

AU - Buggage, Ronald R

PY - 2004/8/1

Y1 - 2004/8/1

UR - https://www.sciencedirect.com/science/article/pii/S0896841104000502

U2 - 10.1016/J.JAUT.2004.04.001

DO - 10.1016/J.JAUT.2004.04.001

M3 - Article

VL - 23

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

IS - 1

ER -

Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]

Disciplines

Access to Document

Other files and links

Cite this